Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Sight Sciences expressed its support for the decision made by five Medicare Administrative Contractors to withdraw their previously announced final local coverage determinations (LCDs) for Micro-Invasive Glaucoma Surgery, originally slated to become effective on January 29, 2024. The five MACs—WPS…

In a significant development in the field of eye care and vision science, the L.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the University of Waterloo have established a strategic partnership. This alliance,…

RevOpsis Therapeutics has announced the successful closure of its first seed funding round, securing a total of $16.5 million. This funding is set to advance the development and commercialization of treatments for chronic multifactorial diseases through the company’s innovative, fully…

Researchers at Seoul National University Hospital in South Korea, led by Chung Young Kim, M.D., have conducted a comprehensive study exploring the link between visual impairment and various aspects of suicide, including behavior, ideation, and death. The study aggregated data…

Laser eye surgery has become a popular solution for correcting vision problems such as nearsightedness, farsightedness, and astigmatism. While the procedure is known for its high success rate and quick recovery times, proper post-operative care is crucial to achieve optimal…

Researchers from the University of the Basque Country (UPV/EHU) and Biobizkaia have explored the potential of using a common ophthalmological tool, optical coherence tomography, to monitor neurodegeneration in patients with Parkinson’s disease. This non-invasive method, commonly employed in eye health…

Verana Health has introduced its Qdata Thyroid Eye Disease (TED) module, a new addition to its suite of data solutions, featuring a comprehensive dataset derived from over 250,000 de-identified patients. This module is designed to enhance the extraction of diagnoses…

LEP Biomedical announced pre-seed funding of €100,000 ($107,000) over two 6-month periods, which the company says will allow for further preclinical milestones in the development of the HyaGuard platform. The funding was made through Enterprise Ireland. Innovative Design of HyaGuard…

SalioGen Therapeutics announced the selection of SGT-1001 as a development candidate for Stargardt disease treatment, a rare inherited retinal disease. This innovative therapy, SGT-1001, is designed as a one-time, non-viral intervention aimed at slowing or halting the progressive central vision…

Phoenix-Micron announced a new collaboration with ArtiKode Intelligence, a pioneering artificial intelligence (AI) and machine learning company based in Valencia, Spain. This partnership aims to advance the capabilities of the MICRON Software Suite through automated optical coherence tomography (OCT) segmentation…